NALOXONE OrPha sol inj 0.4 mg/ml 10 amp 1 ml
7680569520015
CH-56952
V03AB15
15.01.1.
Active substances:
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 5695201
- CPT
- -
- Packaging group
- 10
- Unit
- Ampulle(n)
- Composition
- naloxoni hydrochloridum anhydricum 0.4 mg ut naloxoni hydrochloridum dihydricum 0.44 mg, natrii chloridum, natrium 3.54 mg, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Articles (1)
Naloxon OrPha, Injektionslösung
Injektionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
naloxoni hydrochloridum anhydricum
|
0.4 MG | Substance | Wirkstoff (Principe actif) |
|
naloxoni hydrochloridum dihydricum
|
0.44 MG | Substance | WIZUS |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrium
|
3.54 MG | Substance | HBESI |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 56952
- Drug name
- Naloxon OrPha, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- V03AB15
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 07/06/2004
- Authorization expiration date
- 31/12/9999
- IT number
- 15.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NALOXONE OrPha sol inj 0.4 mg/ml 10 amp 1 ml
- Description (DE)
- NALOXON OrPha Inj Lös 0.4 mg/ml 10 Amp 1 ml
- Market launch
- 07/06/2004
- Narcotic (BTM)
- No